Marianne
Brydøy
Post doctor
Visit Address:
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
E-mail:
Journal articles
- 2014. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors. Journal of Clinical Oncology. 32: 571-578. doi: 10.1200/JCO.2013.51.2715
- 2014. Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy. Acta Oncologica. 53: 1048-1057. Published 2014-06-14. doi: 10.3109/0284186X.2014.928420
- 2013. Impact of testicular scatter radiation (TSR) on testosterone (T) and luteinizing hormone (LH) 11 and 18 years after abdominal radiotherapy for testicular cancer. European Journal of Cancer. 49: S647-S648.
- 2012. Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer. British Journal of Cancer. 107: 1833-1839. doi: 10.1038/bjc.2012.471
- 2012. Testicular germ cell tumours - still many challenges. Acta Oncologica. 51: 147-150. doi: 10.3109/0284186X.2011.653441
- 2012. Long term and late effects of germ cell testicular cancer treatment and implications for follow-up. Journal of Clinical Oncology. 30: 3752-3763. doi: 10.1200/JCO.2012.43.4431
- 2012. Longitudinal serum testosterone levels (T) in long-term testicular cancer survivors (TCSs) in relation to testicular cancer (TC) treatment, aging, and TC diagnosis itself. Journal of Clinical Oncology. 30. 1 pages.
- 2010. Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy. European Urology. 58: 134-140. doi: 10.1016/j.eururo.2010.03.041
- 2009. Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. 101: 1682-1695. doi: 10.1093/jnci/djp413
- 2009. Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. Journal of the National Cancer Institute. 101: 1682-1695.
- 2009. Pulmonary Function in Long-Term Survivors of Testicular Cancer. Journal of Clinical Oncology. 27: 2779-2786. doi: 10.1200/JCO.2008.18.5181
- 2008. Pulmonary function in long-term testicular cancer survivors. Annals of Oncology. 19: viii205.
- 2007. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncologica. 46: 480-489. doi: 10.1080/02841860601166958
- 2007. Transient neurological adverse effects following low dose radiation therapy for early stage testicular seminoma. Radiotherapy and Oncology. 82: 137-144. doi: 10.1016/j.radonc.2006.11.022
- 2007. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in lutathione-s-transferase-P1 and -M1, a retrospective cross sectional study. Journal of Translational Medicine. 5: 70. doi: 10.1186/1479-5876-5-70
- 2007. Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study. Journal of Translational Medicine. 5. doi: 10.1186/1479-5876-5-70
- 2006. Self-reported paresthesias, Raynaud's phenomena, tinnitus, and hearing impairment in a large cohort of long-term testicular cancer (TG) survivors. Journal of Clinical Oncology. 24: 228S-228S.
- 2006. Self-reported paresthesia, Raynaud,s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. Journal of Clinical Oncology. 24: 228s.
- 2006. The effects of cancer and cancer treatments on male reproductive function. Nature Clinical Practice Urology. 3: 312-322. doi: 10.1038/ncpuro0508
- 2005. Self-reported paresthesia, Raynaud’s phenomena, tinnitus, and hearing impairment in long-term testicular cancer (TC) survivors. European Journal of Cancer. 3.
- 2005. Gonadal hormones, sperm counts and post-treatment paternity in long-term survivors of unilateral testicular cancer. European Journal of Cancer. 3: 228s.
- 2005. Paternity Following Treatment for Testicular Cancer. Journal of the National Cancer Institute. 97: 1580-1588. doi: 10.1093/jnci/dji339
- 2005. Paternity following treatment for testicular cancer. Journal of the National Cancer Institute. 97: 1580-1588.
- 2004. Post-treatment paternity in testicular cancer survivors. Proceedings of the Annual Meeting of the American Society for Clinical Oncology. 23. 1 pages.
Book sections
- 2009. Alkylerende midler. Kapittel 11, pages 156-176. In:
- 2009. Medikamentell kreftbehandling. 495 pages. ISBN: 978-829923312-5.
More information in national current research information system (CRIStin)
